Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Agents and Actions|October 1, 1984
Differential effects of pharmacologic agents on the reverse passive Arthus reaction in guinea pigsZ E Mielens, J C Bhandari, T A Barbolt, et al.
International Journal of Immunopharmacology|April 1, 1992
Pre-clinical toxicity of IL-4: a model for studying protein therapeuticsJ H Dean, J B Cornacoff, T A Barbolt, et al.
Toxicologic Pathology|January 1, 1993
Clinical pathologic alterations associated with subcutaneous administration of recombinant human interleukin-4 to cynomolgus monkeysK A Gossett, T A Barbolt, J B Cornacoff, et al.
Neurological Research|January 5, 2002
Biocompatibility evaluation of dura mater substitutes in an animal modelT A Barbolt, M Odin, M Léger, et al.
American Journal of Primatology|February 26, 2020
Enzootic hepatitis A infection in cynomolgus monkeys (Macaca fascicularis)R G Slighter, J P Kimball, T A Barbolt, et al.
The Prostate|January 1, 1990
Effects of androgen and antiandrogen treatment on canine prostatic arginine esteraseP E Juniewicz, T A Barbolt, M A Egy, et al.
Acta Radiologica: Diagnosis|May 1, 1986
Subarachnoid administration of iohexol in cynomolgus monkeysH P Drobeck, B A Mayes, T A Barbolt, et al.
Toxicologic Pathology|January 1, 1989
Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrateA J Spencer, T A Barbolt, D C Henry, et al.
The Prostate|January 1, 1989
Dose-dependent hormonal induction of benign prostatic hyperplasia (BPH) in castrated dogsP E Juniewicz, B M Lemp, T A Barbolt, et al.
The Prostate|January 1, 1990
Effect of the steroidal androgen receptor antagonist Win 49,596 on steroid-induced benign prostatic hyperplasia in the castrate beagle dogP E Juniewicz, B M Lemp, T A Barbolt, et al.
Pageof 3